Facial tissue targets cold and flu germs

Feb. 24, 2006
Kleenex® Anti-Viral Facial Tissue is ideal for patient waiting rooms, and online educational materials are also available.

During cold and flu season, one way to help patients, employees, and visitors kill cold and flu viruses¿ is through the use of KLEENEX® Anti-Viral Facial Tissue. KLEENEX Anti-Viral Facial Tissue is the only facial tissue that kills 99.9 percent of cold and flu viruses(1). When moisture from a runny nose, cough, or sneeze comes in contact with KLEENEX® Anti-Viral Tissue's special middle layer, cold and flu viruses are trapped and killed.

Having a box of these tissues in waiting rooms is a great way to encourage patients to observe "respiratory etiquette" by making it easier for them to cough or sneeze into a tissue. Covering your mouth and nose with a disposable tissue when coughing or sneezing is also one of several recommendations from the Centers for Disease Control (CDC) to help prevent others from getting sick.

"Providing a premium, branded product like this in the waiting room is yet another way to demonstrate to patients that you care, and it's a gesture that they will appreciate," said Henrik Matzen, associate tissue category manager for Kimberly-Clark Professional.

KLEENEX Anti-Viral Facial Tissue is also gentle enough to be used by children as well as the entire family at any time of year. The super-premium three-ply tissue has a special formula on the outer layer for added softness.

Patient information is also available on the following topics:
• Virus Q&A

• Colds and Flu "Mythconceptions"

• Feeling Under the Weather?

• Mom's Stay-Well Tips

• Germ Zappers Game

• Handwashing Checklist

• Color-a-germ
The information can be obtained via the KLEENEX® Brand Web site by visiting www.kleenex.com or call (888) 346-GOKC.

(1) Virucidal against Rhinoviruses Type 1A and 2 (Rhinoviruses are the leading cause of the common cold); Influenza A and Influenza B (causes of the flu); and Respiratory Syncytial Virus (RSV, the leading cause of lower respiratory infections in children) in the tissue within 15 minutes.